Breakwater Capital Group Buys Shares of 2,214 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Breakwater Capital Group bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,214 shares of the exchange traded fund’s stock, valued at approximately $210,000.

Several other institutional investors have also added to or reduced their stakes in XBI. Envestnet Asset Management Inc. raised its holdings in SPDR S&P Biotech ETF by 5.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 126,001 shares of the exchange traded fund’s stock worth $9,201,000 after purchasing an additional 6,884 shares during the period. Synovus Financial Corp increased its stake in SPDR S&P Biotech ETF by 9.3% in the 3rd quarter. Synovus Financial Corp now owns 5,018 shares of the exchange traded fund’s stock worth $366,000 after buying an additional 429 shares in the last quarter. Alerus Financial NA grew its position in shares of SPDR S&P Biotech ETF by 0.6% during the third quarter. Alerus Financial NA now owns 54,655 shares of the exchange traded fund’s stock valued at $3,991,000 after purchasing an additional 349 shares in the last quarter. Sectoral Asset Management Inc. grew its position in shares of SPDR S&P Biotech ETF by 36.8% during the third quarter. Sectoral Asset Management Inc. now owns 24,675 shares of the exchange traded fund’s stock valued at $1,802,000 after purchasing an additional 6,643 shares in the last quarter. Finally, Scotia Capital Inc. grew its position in shares of SPDR S&P Biotech ETF by 4.9% during the third quarter. Scotia Capital Inc. now owns 41,137 shares of the exchange traded fund’s stock valued at $3,004,000 after purchasing an additional 1,933 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.2 %

XBI traded down $0.15 on Friday, hitting $92.71. The company had a trading volume of 7,872,582 shares, compared to its average volume of 10,728,328. The company has a market cap of $7.07 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The business’s fifty day simple moving average is $89.95 and its 200 day simple moving average is $90.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.